RankingsPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Cash from investing

Chiome Bioscience Inc.JP:4583

Market cap
¥7.5B
P/E ratio
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Dec 31, 20230-100.49%
Dec 31, 2021-35+905.51%
Dec 31, 2020-4-86.68%
Dec 31, 2019-26-80.73%
Dec 31, 2017-137-106.89%
Dec 31, 20161,989-211.72%
Dec 31, 2015-1,780

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)